Cargando…

Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative dementia characterized by the decline of cognition and the presence of neuropathological changes including neuronal loss, neurofibrillary pathology and extracellular senile plaques. A neuroinflammatory process is also triggered and compleme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonseca, Maria I, McGuire, Susan O, Counts, Scott E, Tenner, Andrea J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605123/ https://www.ncbi.nlm.nih.gov/pubmed/23394121 http://dx.doi.org/10.1186/1742-2094-10-25

Ejemplares similares

Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization
por: Bujko, Kamila, et al.
Publicado: (2017)

The role of extracellular Tau in the spreading of neurofibrillary pathology
por: Medina, Miguel, et al.
Publicado: (2014)

The human complement fragment receptor, C5L2, is a recycling decoy receptor
por: Scola, Anne-Marie, et al.
Publicado: (2009)

Clinical Neuropathology image 5-2016: neurofibrillary tangle-rich ganglioglioma
por: Gelpi, Ellen, et al.
Publicado: (2016)

Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer’s mouse models
por: Petrisko, Tiffany J., et al.
Publicado: (2023)

Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease
por: Bryan, Kathryn J, et al.
Publicado: (2008)

Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles
por: Nishikawa, Tomokazu, et al.
Publicado: (2014)

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Zhentao, et al.
Publicado: (2014)

Synovial mast cells require C5a receptor (CD88) for arthritis induction
por: Lee, D, et al.
Publicado: (2003)

Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis
por: Furebring, Mia, et al.
Publicado: (2002)

Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology
por: Liu, R, et al.
Publicado: (2008)

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
por: Braak, Heiko, et al.
Publicado: (2006)

Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
por: Hunter, Sally, et al.
Publicado: (2015)

NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain
por: Fadul, Motaz M., et al.
Publicado: (2020)

The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres
por: Crane, James W, et al.
Publicado: (2009)

Complement-targeted therapy: development of C5- and C5a-targeted inhibition
por: Horiuchi, Takahiko, et al.
Publicado: (2016)

Plasmin as a complement C5 convertase
por: Leung, Lawrence L., et al.
Publicado: (2016)

Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay
Publicado: (1983)

C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA
por: Kaida, Takayoshi, et al.
Publicado: (2016)

Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
por: Alafuzoff, Irina, et al.
Publicado: (2008)

Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies
por: Majerova, Petra, et al.
Publicado: (2019)

GM3 Ganglioside Linked to Neurofibrillary Pathology in a Transgenic Rat Model for Tauopathy
por: Olešová, Dominika, et al.
Publicado: (2021)

Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease
por: Zhang, Guoxin, et al.
Publicado: (2022)

An inhibitor of complement C5 provides structural insights into activation
por: Reichhardt, Martin P., et al.
Publicado: (2020)

Complement C3 and Activated Fragment C3a Are Involved in Complement Activation and Anti-Bacterial Immunity
por: Wu, Meng, et al.
Publicado: (2022)

Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer’s disease
por: Camacho, Jessica, et al.
Publicado: (2021)

Complement C3 and C5 Deficiency Affects Fracture Healing
por: Ehrnthaller, Christian, et al.
Publicado: (2013)

Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments
Publicado: (1983)

The allosteric modulation of complement C5 by knob domain peptides
por: Macpherson, Alex, et al.
Publicado: (2021)

The opsonic fragment of the third component of human complement (C3)
Publicado: (1975)

Altered Regulation of KIAA0566, and Katanin Signaling Expression in the Locus Coeruleus With Neurofibrillary Tangle Pathology
por: Andrés-Benito, Pol, et al.
Publicado: (2018)

EXM 88-5
por: Daems, G
Publicado: (1988)

C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta
por: Hernandez, Michael X., et al.
Publicado: (2017)

Modulation of C5a–C5aR1 signaling alters the dynamics of AD progression
por: Carvalho, Klebea, et al.
Publicado: (2022)

In situ Visualization of C3/C5 Convertases to Differentiate Complement Activation
por: Person, Fermin, et al.
Publicado: (2020)

Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2021)

The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics
por: Woodruff, Trent M., et al.
Publicado: (2020)

Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
por: Iqbal, K, et al.
Publicado: (2008)

Genes associated with the progression of neurofibrillary tangles in Alzheimer's disease
por: Miyashita, A, et al.
Publicado: (2014)

The proteome of granulovacuolar degeneration and neurofibrillary tangles in Alzheimer’s disease
por: Hondius, David C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p92jgfc2din6657sbit65rm6im